Insufficient scRNA-seq data for expression of MYOZ1 at single-cell level.
Insufficient scRNA-seq data for expression of MYOZ1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 71% | 232.07 | 465 / 653 | 91% | 11.25 | 552 / 605 |
lung | 73% | 264.56 | 420 / 578 | 59% | 3.39 | 684 / 1155 |
brain | 21% | 47.66 | 554 / 2642 | 97% | 7.63 | 686 / 705 |
ovary | 21% | 67.83 | 38 / 180 | 90% | 8.75 | 387 / 430 |
kidney | 43% | 103.73 | 38 / 89 | 68% | 2.63 | 613 / 901 |
prostate | 18% | 241.00 | 44 / 245 | 84% | 8.28 | 421 / 502 |
muscle | 100% | 104444.53 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.94 | 1 / 1 |
blood vessel | 99% | 1747.76 | 1320 / 1335 | 0% | 0 | 0 / 0 |
breast | 27% | 138.06 | 123 / 459 | 72% | 4.46 | 802 / 1118 |
pancreas | 1% | 1.41 | 2 / 328 | 81% | 2.56 | 144 / 178 |
adrenal gland | 0% | 0.89 | 1 / 258 | 69% | 3.88 | 158 / 230 |
eye | 0% | 0 | 0 / 0 | 66% | 1.98 | 53 / 80 |
heart | 54% | 1132.69 | 466 / 861 | 0% | 0 | 0 / 0 |
uterus | 11% | 29.66 | 18 / 170 | 36% | 7.18 | 167 / 459 |
skin | 5% | 41.39 | 98 / 1809 | 35% | 1.59 | 165 / 472 |
bladder | 10% | 20.29 | 2 / 21 | 31% | 1.35 | 154 / 504 |
tonsil | 0% | 0 | 0 / 0 | 38% | 6.83 | 17 / 45 |
esophagus | 16% | 95.09 | 231 / 1445 | 17% | 0.44 | 32 / 183 |
adipose | 33% | 131.03 | 403 / 1204 | 0% | 0 | 0 / 0 |
liver | 1% | 3.01 | 3 / 226 | 16% | 0.40 | 66 / 406 |
stomach | 3% | 7.98 | 10 / 359 | 14% | 0.26 | 39 / 286 |
intestine | 3% | 11.70 | 32 / 966 | 12% | 0.24 | 62 / 527 |
spleen | 13% | 29.85 | 31 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.25 | 3 / 29 |
peripheral blood | 8% | 153.24 | 73 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043417 | Biological process | negative regulation of skeletal muscle tissue regeneration |
GO_0042060 | Biological process | wound healing |
GO_0030239 | Biological process | myofibril assembly |
GO_0043503 | Biological process | skeletal muscle fiber adaptation |
GO_0045214 | Biological process | sarcomere organization |
GO_0030018 | Cellular component | Z disc |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0031143 | Cellular component | pseudopodium |
GO_0005634 | Cellular component | nucleus |
GO_0004865 | Molecular function | protein serine/threonine phosphatase inhibitor activity |
GO_0051373 | Molecular function | FATZ binding |
GO_0031433 | Molecular function | telethonin binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0042805 | Molecular function | actinin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | MYOZ1 |
Protein name | Myozenin-1 (Calsarcin-2) (Filamin-, actinin- and telethonin-binding protein) (Protein FATZ) |
Synonyms | MYOZ |
Description | FUNCTION: Myozenins may serve as intracellular binding proteins involved in linking Z-disk proteins such as alpha-actinin, gamma-filamin, TCAP/telethonin, LDB3/ZASP and localizing calcineurin signaling to the sarcomere. Plays an important role in the modulation of calcineurin signaling. May play a role in myofibrillogenesis. |
Accessions | Q9NP98 ENST00000359322.5 |